Selective Laser Trabeculoplasty (SLT): A Breakthrough in Glaucoma Management

Glaucoma is a progressive eye disease that can lead to irreversible vision loss if left untreated. It occurs when elevated intraocular pressure (IOP) damages the optic nerve, often without noticeable symptoms in the early stages. Traditional treatments include eye drops, oral medications, and surgical procedures to reduce IOP and prevent further damage. However, many patients struggle with the long-term use of medications due to side effects or adherence issues.
 

Selective Laser Trabeculoplasty (SLT) has emerged as an effective, minimally invasive treatment for glaucoma. This innovative laser therapy offers patients a safe and reliable alternative to medication, improving eye pressure control while reducing dependence on daily drops.
 

How SLT Works

SLT is a quick, in-office laser procedure that enhances the drainage of fluid from the eye, effectively lowering intraocular pressure. Unlike other laser treatments, SLT uses low-energy, short-pulse laser light to target specific pigmented cells in the trabecular meshwork—the eye's natural drainage system—without causing significant damage to surrounding tissues.
 

The procedure stimulates the body's natural healing response, encouraging the drainage system to function more efficiently. As a result, fluid outflow improves, and intraocular pressure decreases over time.
 

Benefits of SLT for Glaucoma Patients

Many glaucoma patients are turning to SLT for its numerous advantages, including:

• Non-invasive and Painless: SLT is performed in an outpatient setting with no incisions or stitches. The procedure is virtually painless, requiring only anesthetic eye drops for comfort.

• Quick Procedure with Minimal Downtime: The entire treatment takes about 5-10 minutes per eye, and patients can typically resume normal activities the same day.

• Long-Lasting Results: SLT can lower intraocular pressure for months to years, and the procedure can be repeated if necessary.

• Reduced Dependence on Medications: Many patients experience significant pressure reduction, allowing them to decrease or even eliminate the use of glaucoma eye drops.

• Safe and Well-Tolerated: SLT has a low risk of complications, making it a preferred option for those who cannot tolerate or adhere to glaucoma medications.
   

Who is a Candidate for SLT?

SLT is an excellent option for patients with open-angle glaucoma, the most common form of the disease. It may be recommended as a first-line treatment for newly diagnosed individuals or as an alternative for those who struggle with medication adherence. Patients who have previously undergone SLT can often have the procedure repeated for additional pressure control.
 

However, SLT may not be suitable for individuals with certain types of glaucoma, such as closed-angle glaucoma or advanced cases requiring more aggressive intervention. A comprehensive eye exam and consultation with an eye doctor are necessary to determine candidacy.
 

Schedule Your Glaucoma Consultation Today

Selective Laser Trabeculoplasty is revolutionizing glaucoma treatment by providing a safe, effective, and medication-free alternative for lowering intraocular pressure. For many patients, SLT offers long-term pressure control while reducing the burden of daily eye drops. We are committed to providing cutting-edge treatments to protect your vision. Our experienced eye care specialists can assess your condition and determine if SLT is the best option for your glaucoma management. 
 

If you have been diagnosed with glaucoma or are seeking better management options, contact Volusia Eye Associates to discover if Selective Laser Trabeculoplasty is the right solution for you. Visit our office in New Smyrna Beach or Edgewater, Florida. Call (386) 427-4143 or (386) 230-0300 to book an appointment today.